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Abstract. This study aimed to develop films for potential delivery of omeprazole (OME) via the buccal
mucosa of paediatric patients. Films were prepared using hydroxypropylmethylcellulose (HPMC), meth-
ylcellulose (MC), sodium alginate (SA), carrageenan (CA) and metolose (MET) with polyethylene glycol
(PEG 400) as plasticiser, OME (model drug) and L-arg (stabiliser). Gels (1% w/w) were prepared at 40°C
using water and ethanol with PEG 400 (0–1% w/w) and dried in an oven (40°C). Optimised formulations
containing OME and L-arg (1:1, 1:2 and 1:3) were prepared to investigate the stabilisation of the drug.
Tensile properties (Texture analysis, TA), physical form (differential scanning calorimetry, DSC; X-ray
diffraction, XRD; thermogravimetric analysis, TGA) and surface topography (scanning electron micros-
copy, SEM) were investigated. Based on the TA results, SA and MET films were chosen for OME loading
and stabilisation studies as they showed a good balance between flexibility and toughness. Plasticised
MET films were uniform and smooth whilst unplasticised films demonstrated rough lumpy surfaces. SA
films prepared from aqueous gels showed some lumps on the surface, whereas SA films prepared from
ethanolic gels were smooth and uniform. Drug-loaded gels showed that OME was unstable and therefore
required addition of L-arg. The DSC and XRD suggested molecular dispersion of drug within the
polymeric matrix. Plasticised (0.5% w/w PEG 400) MET films prepared from ethanolic (20% v/v) gels
and containing OME: L-arg 1:2 showed the most ideal characteristics (transparency, ease of peeling and
flexibility) and was selected for further investigation.
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INTRODUCTION
Amongst all the established routes of drug administration,
the oral route is perhaps the most preferred for both patients
and healthcare providers compared to other routes such as
injections. However, this route of administration has disadvan-
tages including enzyme degradation within the gastrointestinal
tract which prohibits oral administration of certain classes of
drugs such as peptides and proteins. Evidence has shown that
the oral mucosa is relatively permeable with a rich supply of
blood and shows a short recovery time after stress or damage.
Further, it also lacks Langerhans cells which allow the oral cavity
to be tolerant of any potential allergens [1]. Drug administration
within the oral mucosa is generally classified into sublingual and
buccal delivery. Amongst all the trans-mucosal routes, the buc-
cal mucosa has excellent accessibility, an expanse of smooth
muscle and relatively immobile mucosa, hence suitable for the
administration of retentive dosage forms [2,3]. Direct access to
the systemic circulation through the internal jugular vein by-
passes hepatic first-pass metabolism leading to relatively high
bioavailability compared to the GI tract. Additionally, the buc-
cal mucosa has a high surface area (50.2 cm2) and a thin
membrane (500–600 μm) which can contribute to rapid and
extensive drug absorption [4].
Oral drug delivery systems have always been an impor-
tant means of drug administration; however, many paediat-
ric patients resist solid dosage forms such as tablets due to
the bitter taste and fear of choking. Though sweetened
liquid formulations are commonly used, they present many
challenges including bitter after taste, unpleasant flavours,
short half lives once opened and generally bulky to handle
and store. Oral thin films offer easy administration and
handling, rapid disintegration and dissolution, bypass first-
pass metabolism, enhanced stability and taste masking for
bitter drugs, local and systematic drug delivery, rapid onset
of action and no trained or professional person is required
for paediatric administration [5]. Due to the numerous ad-
vantages of buccal dosage forms, various technologies have
been explored to manufacture oral films on a large scale as
an alternative to traditional dosage forms such as tablets
and capsules [6].
Numerous buccal delivery systems in the form of tablets,
liquids and semi-solids have been reported in the past de-
cades, yet only a limited number of these have reached the
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market [7]. The necessity of recurrent dosing might possibly
arise due to the flushing activity of saliva, chewing and the
ingestion of food materials which results in the rapid expulsion
of drugs. Moreover, the drugs in the saliva may be unevenly
distributed, which might consequently lead to lower amounts
being absorbed by the mucosal tissues directly into the sys-
temic circulation. Furthermore, the likely displacement of the
formulation from the buccal area by tongue movements serves
as an additional challenge [8]. The above notwithstanding, the
buccal mucosal route is still considered a practical route to
deliver a variety of active ingredients.
Hydrophilic polymers incorporating several hydrogen
bonding groups make the formulation of bioadhesive buccal
formulations feasible. Modified forms of such hydrogel poly-
mers with better bioadhesivity create second-generation mu-
cosal dosage forms [9]. In the present study, we report on the
development of solvent cast films for buccal delivery in pae-
diatric patients using various hydrogel polymers generally
regarded as safe (GRAS) and used in mucosal formulations
[10–13] including HPMC, MC, CA, MET, SA, plasticiser
(PEG 400), OME (model drug) and L-arg (to stabilise
OME). Various parameters such as drying times and temper-
atures, casting solvents as well as polymer and plasticiser
concentrations were investigated and the films subsequently
characterised as part of the development and optimisation.
METHODS
Materials
Carrageenan (CA) and sodium alginate (SA) were gifts
from FMC BioPolymer and originally sourced from Cork (Re-
public of Ireland).Metolose (MET)was obtained fromShinEtsu
(Stevenage, Hertfordshire). Hydroxypropylmethylcellulose
(HPMC), methylcellulose (MC), polyethylene glycol (PEG
400), L-arginine (L-arg) were obtained from Sigma-Aldrich (Gil-
lingham, UK). Ethanol was purchased from Fisher Scientific
(Loughborough, UK) and Omeprazole (OME) obtained from
TCI (Tokyo, Japan).
Formulation (Gel and Film) Development
Aqueous and ethanolic gels of the different polymers
were prepared prior to film casting.
The aqueous gels were formulated by adding the required
weight of polymers to the relevant solvent (deionised water)
at laboratory temperature (22°C) to obtain 1% w/w gels.
Following complete hydration (dissolution), the polymeric
gels were heated to 40°C. Based on the total weight of poly-
mers, various amounts of the plasticiser (PEG) were added to
obtain different concentrations (0.00, 0.10, 0.25, 0.50, 0.75 and
1.00% w/w) in the final gels prepared. The resultant gels were
left on a water bath with regulated temperature of 40°C
(except for CAR which was prepared at 70°C) and stirring
continued for 30 min to achieve a homogeneous dispersion.
For ethanolic gels, the appropriate volume of ethanol (10 and
20% v/v) was added to yield the 1% w/w total concentration.
The solution was left to cool to room temperature and stirred
again for 30 min. The final solutions were left to stand over-
night to remove entrapped air bubbles. After removal of the
air bubbles, 20 g of each gel was poured into Petri dishes
(86 mm diameter) and kept in a pre-heated oven at 60°C for
24 h. The dried films were then carefully peeled off from the
Petri dish, images captured using a digital camera and trans-
ferred into poly bags and placed in a desiccator over silica gel
at room temperature until required.
Formulation Development and Optimization of OME-
Loaded Films
The main purpose for the development and optimiza-
tion was to determine the optimised amount of the drug
that could be incorporated into the solvent cast film whilst
still maintaining the ideal physical characteristics in terms
of flexibility, homogeneity and transparency [14]. The
OME-loaded films were obtained by initially preparing
MET gels as previously described above. However, the
drug was added to the appropriate volume of water/
ethanol to form an OME solution as shown in Table I.
The polymer was then added slowly to the vigorously
stirred drug solution at room temperature to obtain the
drug-loaded gels. The resulting gels were covered with
parafilm as above and left overnight to allow air bubbles
to escape, and then 20 g was poured into Petri dishes and
dried at 40°C [15].
Stabilisation of OME in Drug-Loaded MET Films
Using L-Arg
Due to the breakdown of OME following gel forma-
tion, L-arg was used as a stabilising agent to prevent drug
degradation. Table II shows the details for the different
ratios of OME and L-arg in the gel formulations which
were investigated. This step was performed by using dif-
ferent amounts of L-arg within the gel whilst keeping the
original OME concentration (0.10% w/w) constant. The
gels were prepared as above with L-arg and OME dis-
solved in the solvent before addition of MET and PEG
400.
Table I. Drug Loaded MET Gels Formulated Using Different Solvent Systems and Containing Different Amounts of PEG 400 (0 and 0.5% w/w)
Solvent systems Water:ethanol (ml) MET (g) OME (g)
Plasticizers (g)
0% 0.5%
Water 50:0 (1:0) 0.50 0.10 0.00 0.25
10% v/v ethanol 45:5 (9:1) 0.50 0.10 0.00 0.25
20% v/v ethanol 40:10 (4:1) 0.50 0.10 0.00 0.25
MET metolose, OME omeprazole
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Characterisation of the Films
Tensile Characterisation by Texture Analysis
Texture analysis (TA) was used to measure tensile proper-
ties. A texture analyser (HD plus, Stable Micro System, Surrey,
UK) equipped with 5-kg load cell was used. Thickness and width
of the films were measured and stress and strain values were
calculated based on these values. Data evaluation was per-
formed by texture exponent-32 software program. The films
free from any physical defects, with the average thickness of
(0.07±0.01 mm) were selected for testing. The films were cut
into dumbbell-shaped strips and fixed between two tensile grips
positioned 30 mm apart and stretched at a test speed of 1.0 mm/s
to break point. The tensile strength (brittleness of the film),
elastic modulus (rigidity) and percentage elongation (flexibility
and elasticity) were determined using Eqs. 1, 2 and 3. Each
testing was carried out in triplicate (n=3).
Tensile strength ¼
force at failure
cross‐sectional area of the film
ð1Þ
Percent elongation at break ¼





slope of stress‐strain curve
film thickness cross head speed
ð3Þ
Scanning Electron Microscopy (SEM)
SEM was used to investigate the surface morphology
of the films and to cheque for film uniformity and the
presence of any cracks. The films were analysed using a
Hitachi Triple detector CFE-SEM SU8030 (Roland
Schmidt, Hitachi High-Technologies Europe GmbH) scan-
ning electron microscope. Films were mounted onto
12 mm aluminium pin stubs (G301, Agar Scientific) with
double-sided adhesive carbon tapes (G3347N, Agar scien-
tific) and chrome coated (Sputter Coater S150B, 15 nm
thickness). The coated films were analysed at 2 kV accel-
erating voltage.
Differential Scanning Calorimetry (DSC)
DSC was used to characterise the thermal behaviour of
selected optimised MET and SA films and pure materials
to investigate changes in their properties with introduction
of PEG and drug within the films. Analysis of the films
and starting materials were carried out on a Q2000 (TA
Instruments) calorimeter. About 2.5 mg of each sample was
Table II. Different OME:L-arg Ratios in the MET Gel Formulations for Preparing Both Unplasticised and Plasticised Films (0 and 0.5% w/w
(PEG 400), Respectively)
Solvent systems Water:ethanol (ml) MET (g) Drug (g) OME
OME:L-arg (g) Plasticizers (g)
1:1 1:2 1:3 0% 50%
Water 50:0 (1:0) 0.50 0.10 0.10 0.20 0.30 0.00 0.25
10% v/v ethanol 45:5 (9:1) 0.50 0.10 0.10 0.20 0.30 0.00 0.25
20% v/v ethanol 40:10 (4:1) 0.50 0.10 0.10 0.20 0.30 0.00 0.25
MET metolose, OME omeprazole
Fig. 1. Physical appearance (digital photographs) of films prepared using different polymers,
i.e. sodium alginate (SA), metolose (MET), carrageenan (CA), hydroxypropyl methylcellulose
(HPMC) and methylcellulose (MC)
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placed into hermetically sealed Tzero aluminium pans with
a pin hole in the lid and heated from −40 to 180°C at a
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Fig. 2. Tensile (tensile strength, percent elongation at break and elastic modulus) profiles of




TGA studies were performed using a Q5000 (TA
instrument) thermogravimetric analyser. About 2.5 mg of
sample (films and starting materials, MET and SA) was
placed into hermetically sealed Tzero aluminium pans
with a pin hole in the lid. Samples were heated under
nitrogen atmosphere at a flow rate of 25 ml/min from
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Fig. 2. (Continued)
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X-Ray Diffraction (XRD)
XRD was used to investigate the physical form (crystal-
line or amorphous) of the selected optimised films and starting
materials (MET, SA and PEG). XRD patterns of films and
starting materials were obtained with a DIFFRAC plus instru-
ment (Bruker Coventry, UK) equipped with an XRD com-
mander programme. A Goebel mirror was used as
monochromator which produced a focused monochromatic
CuKα1&2 primary beam (λ=1.54184 Å) with exit slits of 0.6
mm and a Lynx eye detector for performing the experiment.
The operating conditions during the experiment were 40 kV
and 40 mA. Film samples were prepared by cutting into 2 cm2
square strips, mounted on the sample cell and scanned
between 2 theta of 0° to 70° and counting time of 0.1 s step
size.
RESULTS AND DISCUSSION
Formulation Development and Optimisation
Omeprazole is an ideal candidate for buccal drug delivery
using polymeric films as the delivery system, as it degrades
readily in acidic medium and undergoes first-pass metabolism
[16]. The polymers used in this study were chosen because of
their hydrophilic nature. Stirring was applied during gel for-
mulation to prevent formation of lumps which could occur
through incomplete hydration especially for polymers with
high viscosity. The heat (40 or 70°C) reduced the viscosity of
the final gels and helped to facilitate the escape of entrapped
air bubbles caused by stirring and also allowed ease of pouring
into the casting Petri dishes. Ethanol was used as solvent in
addition to deionised water because some polymers/drugs are
more soluble in ethanol than water and the former also helped
to increase the rate of drying. The removal of the air bubbles
entrapped inside the gel was essential to avoid any empty
gaps, which could lead to non-uniform distribution of various
film components. The drying process for unplasticised gels
was shorter (12 h) compared to plasticised gels (18–24 h)
due to the known water affinity of most plasticisers [17].
Visual Evaluation of Films
The MET and SA films were transparent, uniform
and easy to peel from the Petri dishes. However, though
HPMC, MC and CA films were transparent, they were
not uniform due to the presence of air bubbles during
drying, and were difficult to peel off without damaging
Fig. 3. aDegradation ofOME in aqueous gel as evidenced by change in colour to redwithin 20
min of preparation, b films prepared from gels containing OME without L-arg showing OME
degradation and c films prepared from gels containing OME stabilised with L-arg
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the films (Fig. 1). Further, HPMC and MC films showed
excessive elasticity at high concentrations of PEG which
made them sticky. As a result, films prepared using CAR,
HPMC and MC were discontinued from further investiga-
tions and only MET and SA films were taken forward for
further development and drug loading.
Further development of MET and SA films, during
the preliminary experiments, involved preparing films with
and without plasticiser. The main purpose of using
plasticiser is to provide flexibility and to overcome the
brittleness in films. Unplasticised MET and SA films were
brittle whilst films plasticised with PEG showed reduced
brittleness and desirable flexibility [18]. Optimum
plasticiser concentration(s) for further formulation
development was however, investigated by using texture
analysis to determine film tensile properties which provid-
ed more reliable data for accurate evaluation.
Tensile Properties of Films
Generally, soft and weak polymers have low tensile
strength, low elastic (Young’s) modulus and low percent elon-
gation at break. On the other hand soft and strong polymers
display acceptable strength, low elastic modulus and high
percent elongation at break [17]. The films showed significant
differences in the tensile strength (brittleness) based on the
PEG concentration. The initial linear portion of the stress-
strain curve was used to estimate the elastic modulus and
Fig. 4. Scanning electron microscope images of aMET films cast from aqueous and ethanolic (10 and 20% v/v) gels
containing different concentrations of PEG 400 (0 and 0.50% w/w) and b SA films cast from aqueous and ethanolic
(10 and 20% v/v) gels containing no PEG 400
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tensile strength [19]. The effects of PEG concentration on the
tensile strength values of the MET and SA films are shown in
Fig. 2a, b, respectively. The percent elongation at break point
of MET gradually increased with increased concentration of
PEG. It has been suggested that the average percent elonga-
tion at break point should ideally be between 30 and 50% [17]
which indicates a good balance between flexibility and elas-
ticity. MET films prepared from gels containing 0.5 and 0.75%
w/w of PEG satisfied this criteria. MET films prepared from
aqueous and ethanolic (water, 10 and 20% v/v of EtOH) gels
containing 0.50% w/w PEG, showed percent elongation of
break values between 27 and 57%. Unplasticised films pre-
pared using water as the casting solvent showed a very low
percent elongation at break (Fig. 2a), whilst films obtained
from EtOH (10 and 20% v/v) gels showed a significantly
higher values of percent elongation. There was also a general
increase in percent elongation with increasing concentration
of PEG for all films. At the concentration of 0.75% w/w of
PEG, all the films showed elongation at break point of 55–
58% which was deemed high. Compared to MET films, SA
films demonstrated low values in the overall percent in elon-
gation at break.
Generally, plasticisers such as PEG in the system increase
the free volume between the polymeric chains and allow them
to slide past each other and subsequently produced appropri-
ate flexibility and consequent decrease in tensile strength and
elastic modulus [20]. Based on these observations all subse-
quent gels for drug loading were prepared using only MET at
two concentrations (0.00 and 0.50% w/w (original gel) of
PEG, with the unplasticised films being used as a control.
Physical Evaluation of Drug-Loaded Films
When OME is added to water, it dissolves quickly to
produce a clear solution. After adding polymer and desired
amount of plasticiser in solution for gel formation, the stability
of OME plays a vital role in the overall stability of the gel [21].
However, it was observed that OME degraded within 20 min
and changed the colour of the gel to red as can be seen in Fig.
3a. This resulted in a completely opaque and brown coloured
film as shown in Fig. 3b. OME can only be stable in alkaline
solution with pH of eight and stability can be achieved in two
main ways: (i) introducing cyclo-dextrin or (ii) L-arg to the
drug-loaded gel. However, because of the toxicity of cyclo-
dextrin for paediatric patients, use of L-arg was the preferred
option [22]. To determine the optimum concentration of L-arg
required to stabilise the drug and determine its effect on MET
film properties, different amounts relative to the drug were
added to the original gels before drying as shown in Table II
above. Blank MET films showed complete transparency sim-
ilar to that shown in Fig. 1; whereas drug-loaded films con-
taining L-arg were slightly cream in colour as shown in Fig. 3c.
Generally, plasticised drug-loaded films containing
OME and L-arg (1:1; 1:2 and 1:3) showed a significant
difference in their visual appearance compared to
unplasticised films with the former showing better trans-
parency and uniformity. Another difference observed be-
tween the different formulations was that the films
prepared from aqueous only gels were difficult to peel off
from the Petri dish due to their thin nature. Further, the
distribution of OME and L-arg was more uniform in the
films prepared from the ethanolic gels (10 and 20% v/v
EtOH). It was therefore concluded that films prepared
from ethanolic gels (EtOH 20%) were the most transpar-
ent and uniform which could be due to complete molecular
dispersion of drug (OME) and L-arg within the polymeric
matrix.
Based on the visual observation and the expected char-
acteristics for an ideal film in terms of flexibility, uniformity
and transparency, films prepared from ethanolic gels (20% v/v
EtOH) containing 1:2 ratio of OME: L-arg and 0.5% w/w
PEG400 was the most appropriate for further investigations.
It was also obvious that the addition of L-arg helped to stabi-
lise the drug within the films as can be seen by comparing
Fig. 5. DSC thermograms of a pure PEG and pure MET, b represen-
tative optimum blank, plasticized (0.50% w/w PEG 400) MET films
cast from ethanolic (20% v/v) gels and c pure L-arg, pure OME and
drug loaded MET film prepared from ethanolic (20% v/v) gels con-
taining OME: L-arg (1:2) and PEG 400 (0.50% w/w)
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Fig. 3b and c, with the latter showing desired homogeneity,
transparency and uniform drug distribution. Figueiras et al.
[23] suggested that when combined together, the H atom of
the L-arg was observed to be in closer proximity to the nitro-
gen atom of OME. They also observed that the distance
between the H (L-arg) and the N (OME) is relatively small
which increases the chances of formation of hydrogen bonds
between the two compounds.
Scanning Electron Microscopy (SEM)
SEM images of the MET films cast from gels prepared
with different solvents (water, 10% EtOH and 20% EtOH)
with or without PEG (0.50% w/w) are shown in Fig. 4a.
The microscopic appearance of all MET films, showed
continuous sheets with relatively smooth and homogeneous
surfaces and suggest that all the components were uniform-
ly mixed during gel formation. The plasticised films showed
smooth and homogeneous surfaces whilst unplasticised
films showed rougher surfaces with some lumps. The sur-
face topography of the SA films was dependent on the
solvent used during gel preparation. Films prepared from
aqueous gels showed considerably rougher surfaces than
films prepared using 10% v/v EtOH, which in turn showed
uneven surfaces than films prepared using 20% v/v EtOH
as shown in Fig. 4b. This could be related to the more
rapid drying of ethanolic gels during film formation. Such
differences in surface topography could influence the uni-
formity of the films, because any pores or lumps in the film
could affect the subsequent functional performance of dif-
ferent formulations with respect to hydration capacity/
swell ing studies , mucoadhesion and drug release
characteristics.
Differential Scanning Calorimetry (DSC)
The thermogram for pure MET and SA can be seen in
Fig. 5a, showing a broad endothermic peak at between 80 and
95°C, caused by evaporation of water and no definite melt or
glass transition peaks. In general, the thermograms of the
films shown in Fig. 5b were similar to the pure MET powder.
Figure 5b further shows the different MET films [aqueous and
ethanolic (10 and 20% EtOH)] which were prepared using
different percentages of PEG 400. All the films can be
characterised as amorphous, as only the broad endothermic
peak can be observed between 40 and 100°C which is attrib-
uted to water loss.
Fig. 6. XRD diffractograms for pure MET, pure PEG, pure OME, L-arg, blank MET films, and drug loaded MET films,
showing amorphous drug distribution in the drug loaded films
Table III. Weight Loss Observed for MET Films Cast from Water,
Ethanol (10% v/v) and Ethanol (20% v/v) Gels Containing Different
Concentrations of PEG 400 (0, 0.25, 0.50 and 0.75% w/w)
MET Blank Films
Films Weight loss (%)
MET, 0.00% PEG, aqueous 2.77
MET, 0.25% PEG, aqueous 1.74
MET, 0.50% PEG, aqueous 2.03
MET, 0.75% PEG, aqueous 2.75
MET, 0.00% PEG, 10% EtOH 2.26
MET, 0.25% PEG, 10% EtOH 1.60
MET, 0.50% PEG, 10% EtOH 2.12
MET, 0.75% PEG, 10% EtOH 2.47
MET, 0.00% PEG, 20% EtOH 2.64
MET, 0.25% PEG, 20% EtOH 1.80
MET, 0.50% PEG, 20% EtOH 1.99
MET, 0.75% PEG, 20% EtOH 2.17
MET metolose, PEG polyethylene glycol, EtOH ethanol
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The DSC thermograms for pure OME, L-arg and drug-
loaded MET (OME: L-arg 1:2, 0.50% PEG, EtOH 20% v/v)
films are shown in Fig. 5c. It can be observed that OME has a
melting point at 158°C and L-arg at 100°C and broad endo-
thermic peak which can be seen at 80°C for the drug (L-arg)-
loaded film representing water loss and a complete absence of
the melt peaks for both OME and L-arg. This suggests amor-
phous drug formation or molecular dispersion of both OME
and L-arg within the MET film matrix.
Thermogravimetric Analysis (TGA)
The TGA results of blank films (aqueous and ethanolic)
are shown in Table III indicating the percentage loss with
heating, attributed to residual water present within the film
matrix. Due to PEG having hydrophilic characteristics, it was
expected that the residual moisture content will increase for
all films with increasing PEG 400 concentration. However, this
was not the case except at higher concentrations (0.50 and
0.75% w/w of PEG) where the percent of water content
increased. It also appears that the residual water was generally
lower for films prepared using ethanolic gels than those from
aqueous gels which is to be expected as there was less water in
the original gel and ethanol generally allows faster drying than
pure water on its own. In addition, the moisture content of less
than 3% in all films was considered low enough to sustain drug
stability during storage though this will need to be investigated
with an accelerated stability study.
X-Ray Diffraction (XRD)
To investigate the crystalline-amorphous characteristics
of all initial compounds and of the films, XRD was used.
Amorphous compounds generally show very broad peaks, in
comparison to the sharp peaks belonging to the crystalline
form. XRD can also give information about the crystalline-
amorphous ratios for the various starting materials and the
formulated films [24]. Figure 6 shows XRD diffractograms of
pure MET and PEG 400, generally indicating the amorphous
nature of MET and plasticiser. Figure 6 also shows the
diffractogram of blank plasticised MET films with broad peaks
indicating amorphous characteristics as was observed in the
pure polymers as well as the diffractograms of pure OME, L-
arg and drug-loaded film (20% v/v EtOH, 0.5% w/w PEG,
OME: L-arg 1:2). As can be seen, the results demonstrate that
the drug-loaded film was also amorphous suggesting possible
molecular dispersion of the drug. This is interesting as it
confirms the DSC results previously discussed and also the
fact the MET together with L-arg were able to successfully
maintain the stability of OME in amorphous form within the
film matrix during formulation and storage prior to analysis.
These results are interesting, however, it is well known that
the amorphous forms are generally unstable and have the
tendency to convert back to the amorphous forms. Therefore,
further physical and chemical stability studies under con-
trolled conditions of temperature and humidity (both normal
and accelerated) are required over a longer period of time
(over 1 month) for firm confirmation of its long term stability
in the current physical state.
CONCLUSIONS
Due to the poor stability of OME in aqueous environment,
L-arg was required in drug-loaded films as a stabilising agent.
The most promising characteristics were observed in plasticised
MET films (0.50% PEG 400) prepared from ethanolic (20%
v/v) gels and containing OME: L-arg ratio of 1:2. These charac-
teristics include transparency, ease of peeling and flexibility of
the films for further investigation. It was also confirmed that
OME originally loaded in crystalline form was molecularly dis-
persed (amorphous) within the MET film matrix. The MET
films have potential for paediatric buccal administration and will
be further functionally characterised to determine its in vitro cell
culture, ex vivo and in vivo performance.
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